Low admission HDL-C is an independent predictor of HTG-AP recurrence with a linear risk gradient, and its predictive effect is most pronounced within 12 months after discharge. Given its stability and accessibility, HDL-C can aid early identification of high-risk patients and inform targeted follow-up and prevention strategies.
Liu et al. (2026) studied this question.